Literature DB >> 11699959

Requirement of nef for HIV-1 infectivity is biased by the expression levels of Env in the virus-producing cells and CD4 in the target cells.

M Tobiume1, K Tokunaga, E Kiyokawa, M Takahoko, N Mochizuki, M Tatsumi, M Matsuda.   

Abstract

The nef gene of human immunodeficiency virus type 1 (HIV-1) encodes a 27 to 34 kDa myristoylated protein, which enhances viral infectivity in a single-round infection assay. The level of Nef enhancement of HIV-1 infectivity depends on the viral strains, on the target cells, and on the cells used for propagating the viruses. In this study, we aimed at clarifying the molecular basis of these differences in the requirement for Nef. We found that the requirement for Nef was increased when we decreased the quantity of Env protein in the virus-producing cells or the quantity of CD4 in the target cells. Both the wild-type and Nef-defective HIV-1 viruses were propagated in 293T cells, which did not express any CD4; therefore, Nef-induced CD4 down-regulation did not explain this phenomenon. Moreover, we did not observe any increase in the viral entry or fusion activity of gp120env in the wild-type HIV-1 compared to that in the Nef-defective HIV-1. Thus, we propose that Env on the virion and CD4 on the target cells have inhibitory effects on the post-entry step of the HIV-1 replication cycle, and that Nef functions to counteract this negative effect.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11699959     DOI: 10.1007/s007050170060

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  7 in total

1.  Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes.

Authors:  Evelyne Schaeffer; Vanessa B Soros; Warner C Greene
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

2.  Tracking the Emergence of Host-Specific Simian Immunodeficiency Virus env and nef Populations Reveals nef Early Adaptation and Convergent Evolution in Brain of Naturally Progressing Rhesus Macaques.

Authors:  Susanna L Lamers; David J Nolan; Brittany D Rife; Gary B Fogel; Michael S McGrath; Tricia H Burdo; Patrick Autissier; Kenneth C Williams; Maureen M Goodenow; Marco Salemi
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

3.  SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins.

Authors:  Chetan Sood; Mariana Marin; Ajit Chande; Massimo Pizzato; Gregory B Melikyan
Journal:  J Biol Chem       Date:  2017-02-08       Impact factor: 5.157

4.  Inefficient enhancement of viral infectivity and CD4 downregulation by human immunodeficiency virus type 1 Nef from Japanese long-term nonprogressors.

Authors:  Minoru Tobiume; Mikako Takahoko; Takeshi Yamada; Masashi Tatsumi; Aikichi Iwamoto; Michiyuki Matsuda
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  Association of Nef with p21-activated kinase 2 is dispensable for efficient human immunodeficiency virus type 1 replication and cytopathicity in ex vivo-infected human lymphoid tissue.

Authors:  Michael Schindler; Devi Rajan; Anke Specht; Carolin Ritter; Kati Pulkkinen; Kalle Saksela; Frank Kirchhoff
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

6.  Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles.

Authors:  Massimo Pizzato; Elena Popova; Heinrich G Göttlinger
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

Review 7.  The Nef-infectivity enigma: mechanisms of enhanced lentiviral infection.

Authors:  Jolien Vermeire; Griet Vanbillemont; Wojciech Witkowski; Bruno Verhasselt
Journal:  Curr HIV Res       Date:  2011-10       Impact factor: 1.581

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.